244 related articles for article (PubMed ID: 30264920)
1. Allergic contact dermatitis caused by medical devices for diabetes patients: A review.
Herman A; de Montjoye L; Tromme I; Goossens A; Baeck M
Contact Dermatitis; 2018 Dec; 79(6):331-335. PubMed ID: 30264920
[TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor.
Herman A; Aerts O; Baeck M; Bruze M; De Block C; Goossens A; Hamnerius N; Huygens S; Maiter D; Tennstedt D; Vandeleene B; Mowitz M
Contact Dermatitis; 2017 Dec; 77(6):367-373. PubMed ID: 28804907
[TBL] [Abstract][Full Text] [Related]
3. [Contact allergy due to insulin pumps and glucose sensor systems].
Wagner N; Kamann S; Oppel E
Hautarzt; 2020 Mar; 71(3):205-210. PubMed ID: 31965206
[TBL] [Abstract][Full Text] [Related]
4. Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis?
Herman A; de Montjoye L; Baeck M
Contact Dermatitis; 2020 Jul; 83(1):25-30. PubMed ID: 32212168
[TBL] [Abstract][Full Text] [Related]
5. Contact dermatitis caused by glucose sensors in diabetic children.
Herman A; Darrigade AS; de Montjoye L; Baeck M
Contact Dermatitis; 2020 Feb; 82(2):105-111. PubMed ID: 31657469
[TBL] [Abstract][Full Text] [Related]
6. Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick-set insulin infusion set.
Herman A; Baeck M; de Montjoye L; Bruze M; Giertz E; Goossens A; Mowitz M
Contact Dermatitis; 2019 Dec; 81(6):432-437. PubMed ID: 31385313
[TBL] [Abstract][Full Text] [Related]
7. Contact dermatitis from glucose sensors in Spain: A multicentric approach.
Gatica-Ortega ME; Mowitz M; Pastor-Nieto MA; Navarro-Triviño FJ; Fernández-Redondo V; Hernández-Cano N; Borrego L; Gómez-de-la-Fuente E; Torralba M; Svedman C; Giménez-Arnau A
Contact Dermatitis; 2021 Nov; 85(5):554-562. PubMed ID: 34185891
[TBL] [Abstract][Full Text] [Related]
8. Intense skin reaction to a new glucose monitoring and insulin pump system.
Hamnerius N; Mowitz M
Contact Dermatitis; 2020 Dec; 83(6):524-527. PubMed ID: 32666537
[No Abstract] [Full Text] [Related]
9. Allergic Contact Dermatitis to Components of Wearable Adhesive Health Devices.
Khatsenko K; Khin Y; Maibach H
Dermatitis; 2020; 31(5):283-286. PubMed ID: 32209871
[TBL] [Abstract][Full Text] [Related]
10. Contact Dermatitis to Diabetes Medical Devices.
Cichoń M; Trzeciak M; Sokołowska-Wojdyło M; Nowicki RJ
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445875
[TBL] [Abstract][Full Text] [Related]
11. Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients.
Hyry HSI; Liippo JP; Virtanen HM
Contact Dermatitis; 2019 Sep; 81(3):161-166. PubMed ID: 31206704
[TBL] [Abstract][Full Text] [Related]
12. The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy.
Oppel E; Kamann S; Heinemann L; Reichl FX; Högg C
Contact Dermatitis; 2020 Feb; 82(2):101-104. PubMed ID: 31463958
[TBL] [Abstract][Full Text] [Related]
13. Allergic contact dermatitis caused by isobornyl acrylate in OmniPod, an innovative tubeless insulin pump.
Raison-Peyron N; Mowitz M; Bonardel N; Aerts O; Bruze M
Contact Dermatitis; 2018 Aug; 79(2):76-80. PubMed ID: 29635853
[TBL] [Abstract][Full Text] [Related]
14. Contact dermatitis caused by glucose sensors, insulin pumps, and tapes: Results from a 5-year period.
Ahrensbøll-Friis U; Simonsen AB; Zachariae C; Thyssen JP; Johansen JD
Contact Dermatitis; 2021 Feb; 84(2):75-81. PubMed ID: 32677709
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.
Lombardo F; Salzano G; Crisafulli G; Panasiti I; Alibrandi A; Messina MF; Pajno GB; Caminiti L; Passanisi S
Diabetes Res Clin Pract; 2020 Apr; 162():108089. PubMed ID: 32087268
[TBL] [Abstract][Full Text] [Related]
16. Treatment of generalised isobornyl acrylate contact allergy from diabetes pump with Dupilumab.
Arasu A; Ross G
Australas J Dermatol; 2022 Feb; 63(1):e91-e93. PubMed ID: 34751430
[No Abstract] [Full Text] [Related]
17. Role of acrylates in the development of contact dermatitis in diabetic patients-A Polish dermatology tertiary centre experience.
Cichoń M; Myśliwiec M; Trzeciak M
Contact Dermatitis; 2024 Feb; 90(2):126-133. PubMed ID: 37840370
[TBL] [Abstract][Full Text] [Related]
18. Isobornyl acrylate and diabetic devices steal the Show for the 2020 American Contact Dermatitis Society Allergen of the Year.
Nath N; Reeder M; Atwater AR
Cutis; 2020 Jun; 105(6):283-285. PubMed ID: 32716991
[TBL] [Abstract][Full Text] [Related]
19. Usage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems.
Kamann S; Heinemann L; Oppel E
J Diabetes Sci Technol; 2020 May; 14(3):582-585. PubMed ID: 31538817
[TBL] [Abstract][Full Text] [Related]
20. Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System.
Kamann S; Aerts O; Heinemann L
J Diabetes Sci Technol; 2018 May; 12(3):630-633. PubMed ID: 29542347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
